Abhishek Shankar, VP, Industry Head, Life Sciences Americas, HCL Technologies
The more things change, the more they remain the same. You could arguably apply this theory to the life sciences industry, whose core problems have remained pretty much the same over the last decade.
Bill Humphries, President, Merz North America Inc.
As the North American CEO of a global pharmaceutical company, I constantly face challenges that all CEOs face, with the additional challenge of dealing with an evolving regulatory landscape.
Terry Godier, Medical practitioner, mybiosource.com
ELISA is a popular acronym for an enzyme-linked immunosorbent test that detects as well as measures antibodies in the blood.
Dr. Chitra Lele, Chief Scientific Officer, Sciformix Corporation
Evidence-based medicine has been the mantra for patient treatment and public health for several decades.
Jijo James, M.D., M.P.H., Chief Medical Officer, Johnson & Johnson, Consumer
Data are powerful when leveraged effectively. This is especially true of the healthcare industry where data can be used to help people live longer, happier and healthier lives.
Nataraj Dasgupta, Senior Information Technology Lead, Data Sciences, Systems Development & Analytics, Purdue Pharma L.P.
Big Data is a term that is unusually prone to selective interpretation. If someone tells you that they have Big Data, they are always right. It is not unlike weather predictions, which, like their belief in Big Data.
Manoj Shah, VP-IT, Amneal Pharmaceuticals
We started to look at cloud computing a few years ago out of necessity and it has gradually evolved to become an important part of our IT strategy.
Brad Swarbrick, Owner, Quality by Design Consultancy
In 2011 when the US Food and Drug Administration (US-FDA) published their guidance document on Process Validation (PV), this represented the first real attempt by a regulatory authority to mandate the implementation of the Quality by Design....
Tony Schueth, CEO and Managing Partner, Point-of-Care Partners
Patient-centric educational materials are needed now as never before. Federal mandates require physicians to use electronic health records (EHRs) to meet patient engagement and quality requirements.
Cynthia A. Challener, Ph.D., Scientific Content Director, That’s Nice LLC
Evaluation of the safety and efficacy of new medicines is a crucial component of the drug development process, but one that has become increasingly complex and costly. Clinical trials today are often global